Opsens Past Earnings Performance

Past criteria checks 0/6

Opsens's earnings have been declining at an average annual rate of -40%, while the Medical Equipment industry saw earnings growing at 9.1% annually. Revenues have been growing at an average rate of 9.2% per year.

Key information

-40.0%

Earnings growth rate

-34.0%

EPS growth rate

Medical Equipment Industry Growth8.9%
Revenue growth rate9.2%
Return on equity-36.7%
Net Margin-25.7%
Last Earnings Update31 Aug 2023

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Opsens makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

OTCPK:OPSS.F Revenue, expenses and earnings (CAD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Aug 2348-122911
31 May 2343-152811
28 Feb 2340-132610
30 Nov 2237-13239
31 Aug 2235-11208
31 May 2234-9187
28 Feb 2233-6177
30 Nov 2134-4156
31 Aug 2134-1146
31 May 21341135
28 Feb 21311125
30 Nov 20310135
31 Aug 2029-3145
31 May 2030-5165
29 Feb 2031-6175
30 Nov 1931-5165
31 Aug 1933-2165
31 May 1931-2155
28 Feb 1929-2144
30 Nov 1827-3144
31 Aug 1824-5134
31 May 1823-4123
28 Feb 1821-5123
30 Nov 1720-5113
31 Aug 1718-7113
31 May 1716-8103
28 Feb 1714-10103
30 Nov 1612-1093
31 Aug 1610-973
31 May 168-863
29 Feb 166-653
30 Nov 156-642
31 Aug 155-342
31 May 156-242
28 Feb 157-142
30 Nov 146-142
31 Aug 147-342
31 May 146-432
28 Feb 146-332
30 Nov 137-332
31 Aug 138-232
31 May 137-232
28 Feb 138-232

Quality Earnings: OPSS.F is currently unprofitable.

Growing Profit Margin: OPSS.F is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: OPSS.F is unprofitable, and losses have increased over the past 5 years at a rate of 40% per year.

Accelerating Growth: Unable to compare OPSS.F's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: OPSS.F is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (3.7%).


Return on Equity

High ROE: OPSS.F has a negative Return on Equity (-36.66%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2023/12/13 08:46
End of Day Share Price 2023/12/12 00:00
Earnings2023/08/31
Annual Earnings2023/08/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Opsens Inc. is covered by 8 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
David MartinBloom Burton & Co.
Lelio LatoiA Capital Markets
Jeffrey CohenLadenburg Thalmann & Company